Current Studies

Curis is conducting clinical trials to evaluate the efficacy and safety of potential investigational drug in cancer. See all currently enrolling clinical trials for Curis investigational therapies in the U.S. on clinicaltrials.gov.

TakeAim Leukemia – Phase 1/2 Study of Emavusertib in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) – clinicaltrials.gov NCT04278768

TakeAim Lymphoma – Phase 1/2 Study of Emavusertib in Patients with B Cell Lymphoma – clinicaltrials.gov NCT03328078

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients with Advanced Solid Tumor Malignancies – clinicaltrials.gov NCT04475523